MELBOURNE, Australia and BERLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- (ASX: TLX, Telix, the Company) today announces that it ...

Scientists at Lawrence Berkeley National Laboratory say they have developed the technology that could finally produce the ...

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical ...

EQS-Adhoc: Eckert & Ziegler and Telix Pharmaceuticals Enter into a Collaboration and Licence Agreement for Actinium-225 ...

Among major accomplishments are her contribution to R&D and translation effort for the production of technetium-99m with cyclotron, and implementation of investigational prostate cancer ...